Sign in
4

Changes in Ownership

PDS Biotechnology Corp Filed Acc 0001127602-17-002309

Chief Scientific Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Macdonald R. Loch · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-01-23 Exercise or conversion : show line 1 in the form +25,000 $2.04 $51,000 595,602 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2017-01-23 Exercise or conversion : show line 2 in the form Stock Option (right To Purchase) −25,000 75,504 D
Loading xslF345X03/form4.xml…